@PortfolioPlus and @Jimmy_C,
I appear to have ended up somehow being in the "Apologist for Brazil" camp, which is not what I had intended.
I agree fully that the foray into Brazil has been unsatisfactory for shareholders. But there is a not-insubstantial revenue base there now which - I think - would be crazy to allow to now let it merely wither and die off.
Besides, I think that there is a degree of transfer pricing between the Brazil and Australia segments; so while the segmental accounts might shed Brazil's accounting contribution in a poor light, I have been assured on many occasions that - in terms of the consolidated cash flows of the Group - Brazil's existence washes its own face.
So, I think the descriptor "hemorrhaging" is a bit wide of the mark. I think "not exceeding its cost of capital" is more apt, but then again, they don't have much of a capital base in Brazil. Just a bit of working capital. Less than $1.0m of it, was the answer I received when I asked the question.
But your point, @PortfolioPlus, about SDI needing some kind of local partner to navigate the maze of "local knowledge", is a well-made one. I know they have looked (are looking?) at this as the solution, but the problem with a geography where a not-insignificant amount of business is facilitated by the exchange of brown paper bags is that finding the right partner - one that will not cause reputational contamination by association - is not easy.
I think the point I was trying to make is that Brazil is what it is, and that the market has become inured with it from a valuation point of view:
At best, if it doesn't burn a cash hole in our pockets, then it is a free option on some or other magical distributorship "breakthrough.
At worst, it is a distraction for management.
But I don't see it as a cancer that is rotting the company from within; rather, I think it is quite an inert feature of the company, in valuation terms. A perennial disappointer, in not scoring any goals, sure, but not a millstone around the company's neck either.
- Forums
- ASX - By Stock
- SDI
- Ann: Appendix 4E June 30 2017
Ann: Appendix 4E June 30 2017, page-32
Featured News
Add SDI (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.06 |
Change
0.025(2.43%) |
Mkt cap ! $111.1M |
Open | High | Low | Value | Volume |
$1.04 | $1.06 | $1.04 | $68.79K | 65.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 93344 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.06 | 450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3840 | 0.790 |
1 | 5000 | 0.720 |
2 | 4500 | 0.700 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 3861 | 2 |
0.910 | 5000 | 1 |
0.920 | 10000 | 1 |
0.990 | 9810 | 2 |
0.000 | 0 | 0 |
Last trade - 15.58pm 25/11/2024 (20 minute delay) ? |
Featured News
SDI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online